• Open Access
  • Review Article

Mitophagy in Endothelial Senescence: Implications for Atherosclerosis

  • Dongying Ren and 
  • Xudong Liao *

Received: 21 September 2026 | Revised: 09 November 2026 | Accepted: 10 November 2026 | Published: 19 November 2026

Abstract

Endothelial senescence contributes to vascular dysfunction and the development of atherosclerosis. Mitochondrial damage, oxidative stress and persistent inflammation are closely associated with this process. Mitophagy is an important component of mitochondrial quality control that removes damaged mitochondria and helps maintain endothelial homeostasis. When mitochondrial clearance is impaired, damaged mitochondria can accumulate and promote changes associated with endothelial senescence. In this Review, we discuss the molecular mechanisms of mitophagy, including the PINK1/Parkin pathway and receptor-mediated pathways involving BNIP3, NIX and FUNDC1. We examine how these pathways influence endothelial senescence and function, and assess the evidence for their roles in atherosclerosis. Particular attention is given to the distinction between findings in atherosclerosis models and those in other vascular diseases, as well as to whether the reported effects are mediated by mitophagy. Finally, we discuss the potential of targeting mitophagy to preserve endothelial function and identify questions that remain to be addressed.

Graphical Abstract

References 

  • 1.

    Donato, A.J.; Morgan, R.G.; Walker, A.E.; et al. Cellular and molecular biology of aging endothelial cells. J. Mol. Cell. Cardiol. 2015, 89, 122–135. https://doi.org/10.1016/j.yjmcc.2015.01.021.

  • 2.

    Zhu, X.; Wang, Y.; Soaita, I.; et al. Acetate controls endothelial-to-mesenchymal transition. Cell Metab. 2023, 35, 1163–1178.e10. https://doi.org/10.1016/j.cmet.2023.05.010.

  • 3.

    Claesson-Welsh, L.; Dejana, E.; McDonald, D.M. Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies. Trends Mol. Med. 2021, 27, 314–331. https://doi.org/10.1016/j.molmed.2020.11.006.

  • 4.

    Bloom, S.I.; Islam, M.T.; Lesniewski, L.A.; et al. Mechanisms and consequences of endothelial cell senescence. Nat. Rev. Cardiol. 2023, 20, 38–51. https://doi.org/10.1038/s41569-022-00739-0.

  • 5.

    Kotla, S.; Vu, H.T.; Ko, K.A.; et al. Endothelial senescence is induced by phosphorylation and nuclear export of telomeric repeat binding factor 2–interacting protein. JCI Insight 2019, 4, 124867. https://doi.org/10.1172/jci.insight.124867.

  • 6.

    Han, Y.; Kim, S.Y. Endothelial senescence in vascular diseases: Current understanding and future opportunities in senotherapeutics. Exp. Mol. Med. 2023, 55, 1–12. https://doi.org/10.1038/s12276-022-00906-w.

  • 7.

    Campisi, J.; d’Adda di Fagagna, F. Cellular senescence: When bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 2007, 8, 729–740. https://doi.org/10.1038/nrm2233.

  • 8.

    Mause, S.F.; Weber, C. Microparticles: Protagonists of a novel communication network for intercellular information exchange. Circ. Res. 2010, 107, 1047–1057. https://doi.org/10.1161/circresaha.110.226456.

  • 9.

    Hayashi, T.; Kotani, H.; Yamaguchi, T.; et al. Endothelial cellular senescence is inhibited by liver X receptor activation with an additional mechanism for its atheroprotection in diabetes. Proc. Natl. Acad. Sci. USA 2014, 111, 1168–1173. https://doi.org/10.1073/pnas.1322153111.

  • 10.

    Chala, N.; Moimas, S.; Giampietro, C.; et al. Mechanical Fingerprint of Senescence in Endothelial Cells. Nano Lett. 2021, 21, 4911–4920. https://doi.org/10.1021/acs.nanolett.1c00064.

  • 11.

    Lee, B.Y.; Han, J.A.; Im, J.S.; et al. Senescence-associated β-galactosidase is lysosomal β-galactosidase. Aging Cell 2006, 5, 187–195. https://doi.org/10.1111/j.1474-9726.2006.00199.x.

  • 12.

    Yoshida, Y.; Hayashi, Y.; Suda, M.; et al. Notch signaling regulates the lifespan of vascular endothelial cells via a p16-dependent pathway. PLoS ONE 2014, 9, e100359. https://doi.org/10.1371/journal.pone.0100359.

  • 13.

    Zhang, D.; Sun, X.; Liu, J.; et al. Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase. Arterioscler. Thromb. Vasc. Biol. 2015, 35, 71–78.

  • 14.

    Childs, B.G.; Baker, D.J.; Kirkland, J.L.; et al. Senescence and apoptosis: Dueling or complementary cell fates? EMBO Rep. 2014, 15, 1139–1153. https://doi.org/10.15252/embr.201439245.

  • 15.

    Yin, Y.; Zhou, Z.; Liu, W.; et al. Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway. Int. J. Biochem. Cell Biol. 2017, 84, 22–34. https://doi.org/10.1016/j.biocel.2017.01.001.

  • 16.

    Bent, E.H.; Gilbert, L.A.; Hemann, M.T. A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses. Genes Dev. 2016, 30, 1811–1821. https://doi.org/10.1101/gad.284851.116.

  • 17.

    Hampel, B.; Fortschegger, K.; Ressler, S.; et al. Increased expression of extracellular proteins as a hallmark of human endothelial cell in vitro senescence. Exp. Gerontol. 2006, 41, 474–481. https://doi.org/10.1016/j.exger.2006.03.001.

  • 18.

    Khan, S.Y.; Awad, E.M.; Oszwald, A.; et al. Premature senescence of endothelial cells upon chronic exposure to TNFα can be prevented by N-acetyl cysteine and plumericin. Sci. Rep. 2017, 7, 39501. https://doi.org/10.1038/srep39501.

  • 19.

    Simoncini, S.; Chateau, A.L.; Robert, S.; et al. Biogenesis of Pro-senescent Microparticles by Endothelial Colony Forming Cells from Premature Neonates is driven by SIRT1-Dependent Epigenetic Regulation of MKK6. Sci. Rep. 2017, 7, 8277. https://doi.org/10.1038/s41598-017-08883-1.

  • 20.

    Graves, S.I.; Baker, D.J. Implicating endothelial cell senescence to dysfunction in the ageing and diseased brain. Basic Clin. Pharmacol. Toxicol. 2020, 127, 102–110. https://doi.org/10.1111/bcpt.13403.

  • 21.

    Coleman, P.R.; Hahn, C.N.; Grimshaw, M.; et al. Stress-induced premature senescence mediated by a novel gene, SENEX, results in an anti-inflammatory phenotype in endothelial cells. Blood 2010, 116, 4016–4024. https://doi.org/10.1182/blood-2009-11-252700.

  • 22.

    Oeseburg, H.; Iusuf, D.; van der Harst, P.; et al. Bradykinin Protects Against Oxidative Stress–Induced Endothelial Cell Senescence. Hypertension 2009, 53, 417–422. https://doi.org/10.1161/hypertensionaha.108.123729.

  • 23.

    Vasa, M.; Breitschopf, K.; Zeiher, A.M.; et al. Nitric Oxide Activates Telomerase and Delays Endothelial Cell Senescence. Circ. Res. 2000, 87, 540–542. https://doi.org/10.1161/01.res.87.7.540.

  • 24.

    Matsushita, H.; Chang, E.; Glassford, A.J.; et al. eNOS Activity Is Reduced in Senescent Human Endothelial Cells. Circ. Res. 2001, 89, 793–798. https://doi.org/10.1161/hh2101.098443.

  • 25.

    Nagel, T.; Resnick, N.; Dewey, C.F.; et al. Vascular Endothelial Cells Respond to Spatial Gradients in Fluid Shear Stress by Enhanced Activation of Transcription Factors. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 1825–1834. https://doi.org/10.1161/01.atv.19.8.1825.

  • 26.

    Davignon, J.; Ganz, P. Role of Endothelial Dysfunction in Atherosclerosis. Circulation 2004, 109, III-27–III-32. https://doi.org/10.1161/01.cir.0000131515.03336.f8.

  • 27.

    Hayashi, T.; Yano, K.; Matsui-Hirai, H.; et al. Nitric oxide and endothelial cellular senescence. Pharmacol. Ther. 2008, 120, 333–339. https://doi.org/10.1016/j.pharmthera.2008.09.002.

  • 28.

    Li, L.; Rezvan, A.; Salerno, J.C.; et al. GTP Cyclohydrolase I Phosphorylation and Interaction with GTP Cyclohydrolase Feedback Regulatory Protein Provide Novel Regulation of Endothelial Tetrahydrobiopterin and Nitric Oxide. Circ. Res. 2010, 106, 328–336. https://doi.org/10.1161/circresaha.109.210658.

  • 29.

    Kandhaya-Pillai, R.; Miro-Mur, F.; Alijotas-Reig, J.; et al. TNFα-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion. Aging 2017, 9, 2411–2435. https://doi.org/10.18632/aging.101328.

  • 30.

    Kamino, H.; Hiratsuka, M.; Toda, T.; et al. Searching for Genes Involved in Arteriosclerosis: Proteomic Analysis of Cultured Human Umbilical Vein Endothelial Cells Undergoing Replicative Senescence. Cell Struct. Funct. 2003, 28, 495–503. https://doi.org/10.1247/csf.28.495.

  • 31.

    Grillari, J.; Hohenwarter, O.; Grabherr, R.M.; et al. Subtractive Hybridization of mRNA from early passage and senescent endothelial cells. Exp. Gerontol. 2000, 35, 187–197. https://doi.org/10.1016/s0531-5565(00)00080-2.

  • 32.

    Huo, J.; Xu, Z.; Hosoe, K.; et al. Coenzyme Q10 Prevents Senescence and Dysfunction Caused by Oxidative Stress in Vascular Endothelial Cells. Oxidative Med. Cell. Longev. 2018, 2018, 3181759. https://doi.org/10.1155/2018/3181759.

  • 33.

    Warboys, C.M.; de Luca, A.; Amini, N.; et al. Disturbed Flow Promotes Endothelial Senescence via a p53-Dependent Pathway. Arterioscler. Thromb. Vasc. Biol. 2014, 34, 985–995. https://doi.org/10.1161/atvbaha.114.303415.

  • 34.

    Tang, C.; Shi, G.; Jia, R.; et al. Chronic Disturbed Flow Induces Superficial Erosion-Prone Lesion via Endothelial-to-Mesenchymal Transition in a DNA Methyltransferase-Dependent Manner. J. Atheroscler. Thromb. 2025, 32, 608–629. https://doi.org/10.5551/jat.64990.

  • 35.

    Zhan, H.; Suzuki, T.; Aizawa, K.; et al. Ataxia Telangiectasia Mutated (ATM)-mediated DNA Damage Response in Oxidative Stress-induced Vascular Endothelial Cell Senescence. J. Biol. Chem. 2010, 285, 29662–29670. https://doi.org/10.1074/jbc.m110.125138.

  • 36.

    Spyridopoulos, I.; Isner, J.M.; Losordo, D.W. Oncogenic ras induces premature senescence in endothelial cells: Role of p21Cip1/Waf1. Basic Res. Cardiol. 2002, 97, 117–124. https://doi.org/10.1007/s003950200001.

  • 37.

    Dai, D.F.; Rabinovitch, P.S.; Ungvari, Z. Mitochondria and Cardiovascular Aging. Circ. Res. 2012, 110, 1109–1124. https://doi.org/10.1161/circresaha.111.246140.

  • 38.

    Ungvari, Z.; Labinskyy, N.; Gupte, S.; et al. Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats. Am. J. Physiol.-Heart Circ. Physiol. 2008, 294, H2121–H2128. https://doi.org/10.1152/ajpheart.00012.2008.

  • 39.

    Diao, R.Y.; Gustafsson, Å.B. Mitochondrial quality surveillance: Mitophagy in cardiovascular health and disease. Am. J. Physiol.-Cell Physiol. 2022, 322, C218–C230. https://doi.org/10.1152/ajpcell.00360.2021.

  • 40.

    Cox, R.T.; Poulton, J.; Williams, S.A. The role of mitophagy during oocyte aging in human, mouse, and Drosophila: Implications for oocyte quality and mitochondrial disease. Reprod. Fertil. 2021, 2, R113–R129. https://doi.org/10.1530/raf-21-0060.

  • 41.

    Greene, A.W.; Grenier, K.; Aguileta, M.A.; et al. Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Rep. 2012, 13, 378–385. https://doi.org/10.1038/embor.2012.14.

  • 42.

    Youle, R.J.; Narendra, D.P. Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 2011, 12, 9–14. https://doi.org/10.1038/nrm3028.

  • 43.

    Narendra, D.; Tanaka, A.; Suen, D.F.; et al. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 2008, 183, 795–803. https://doi.org/10.1083/jcb.200809125.

  • 44.

    Okatsu, K.; Oka, T.; Iguchi, M.; et al. PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria. Nat. Commun. 2012, 3, 1016. https://doi.org/10.1038/ncomms2016.

  • 45.

    Yoshii, S.R.; Kishi, C.; Ishihara, N.; et al. Parkin Mediates Proteasome-dependent Protein Degradation and Rupture of the Outer Mitochondrial Membrane. J. Biol. Chem. 2011, 286, 19630–19640. https://doi.org/10.1074/jbc.m110.209338.

  • 46.

    Tanaka, A.; Cleland, M.M.; Xu, S.; et al. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol. 2010, 191, 1367–1380. https://doi.org/10.1083/jcb.201007013.

  • 47.

    Padman, B.S.; Nguyen, T.N.; Uoselis, L.; et al. LC3/GABARAPs drive ubiquitin-independent recruitment of Optineurin and NDP52 to amplify mitophagy. Nat. Commun. 2019, 10, 408. https://doi.org/10.1038/s41467-019-08335-6.

  • 48.

    Lazarou, M.; Sliter, D.A.; Kane, L.A.; et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 2015, 524, 309–314. https://doi.org/10.1038/nature14893.

  • 49.

    Palikaras, K.; Lionaki, E.; Tavernarakis, N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat. Cell Biol. 2018, 20, 1013–1022. https://doi.org/10.1038/s41556-018-0176-2.

  • 50.

    Liu, L.; Sakakibara, K.; Chen, Q.; et al. Receptor-mediated mitophagy in yeast and mammalian systems. Cell Res. 2014, 24, 787–795. https://doi.org/10.1038/cr.2014.75.

  • 51.

    Otsu, K.; Murakawa, T.; Yamaguchi, O. BCL2L13 is a mammalian homolog of the yeast mitophagy receptor Atg32. Autophagy 2015, 11, 1932–1933. https://doi.org/10.1080/15548627.2015.1084459.

  • 52.

    Chinnadurai, G.; Vijayalingam, S.; Gibson, S.B. BNIP3 subfamily BH3-only proteins: Mitochondrial stress sensors in normal and pathological functions. Oncogene 2008, 27, S114–S127. https://doi.org/10.1038/onc.2009.49.

  • 53.

    Hanna, R.A.; Quinsay, M.N.; Orogo, A.M.; et al. Microtubule-associated Protein 1 Light Chain 3 (LC3) Interacts with Bnip3 Protein to Selectively Remove Endoplasmic Reticulum and Mitochondria via Autophagy. J. Biol. Chem. 2012, 287, 19094–19104. https://doi.org/10.1074/jbc.m111.322933.

  • 54.

    Zhu, Y.; Massen, S.; Terenzio, M.; et al. Modulation of Serines 17 and 24 in the LC3-interacting Region of Bnip3 Determines Pro-survival Mitophagy versus Apoptosis. J. Biol. Chem. 2013, 288, 1099–1113. https://doi.org/10.1074/jbc.m112.399345.

  • 55.

    da Silva Rosa, S.C.; Martens, M.D.; Field, J.T.; et al. BNIP3L/Nix-induced mitochondrial fission, mitophagy, and impaired myocyte glucose uptake are abrogated by PRKA/PKA phosphorylation. Autophagy 2021, 17, 2257–2272. https://doi.org/10.1080/15548627.2020.1821548.

  • 56.

    Rogov, V.V.; Suzuki, H.; Marinković, M.; et al. Phosphorylation of the mitochondrial autophagy receptor Nix enhances its interaction with LC3 proteins. Sci. Rep. 2017, 7, 1131. https://doi.org/10.1038/s41598-017-01258-6.

  • 57.

    Lampert, M.A.; Orogo, A.M.; Najor, R.H.; et al. BNIP3L/NIX and FUNDC1-mediated mitophagy is required for mitochondrial network remodeling during cardiac progenitor cell differentiation. Autophagy 2019, 15, 1182–1198. https://doi.org/10.1080/15548627.2019.1580095.

  • 58.

    Murakawa, T.; Yamaguchi, O.; Hashimoto, A.; et al. Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation. Nat. Commun. 2015, 6, 7527. https://doi.org/10.1038/ncomms8527.

  • 59.

    Zhou, H.; Zhu, P.; Wang, J.; et al. DNA-PKcs promotes alcohol-related liver disease by activating Drp1-related mitochondrial fission and repressing FUNDC1-required mitophagy. Signal Transduct. Target. Ther. 2019, 4, 56. https://doi.org/10.1038/s41392-019-0094-1.

  • 60.

    Chen, G.; Han, Z.; Feng, D.; et al. A Regulatory Signaling Loop Comprising the PGAM5 Phosphatase and CK2 Controls Receptor-Mediated Mitophagy. Mol. Cell 2014, 54, 362–377. https://doi.org/10.1016/j.molcel.2014.02.034.

  • 61.

    Wang, Y.; Jasper, H.; Toan, S.; et al. Mitophagy coordinates the mitochondrial unfolded protein response to attenuate inflammation-mediated myocardial injury. Redox Biol. 2021, 45, 102049. https://doi.org/10.1016/j.redox.2021.102049.

  • 62.

    Liu, L.; Feng, D.; Chen, G.; et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol. 2012, 14, 177–185. https://doi.org/10.1038/ncb2422.

  • 63.

    Wu, H.; Xue, D.; Chen, G.; et al. The BCL2L1 and PGAM5 axis defines hypoxia-induced receptor-mediated mitophagy. Autophagy 2014, 10, 1712–1725. https://doi.org/10.4161/auto.29568. Correction in Autophagy 2020, 16, 1554–1555.

  • 64.

    Wu, W.; Tian, W.; Hu, Z.; et al. ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy. EMBO Rep. 2014, 15, 22. https://doi.org/10.1002/embr.201438501.

  • 65.

    Chen, Z.; Liu, L.; Cheng, Q.; et al. Mitochondrial E3 ligase MARCH5 regulates FUNDC1 to fine-tune hypoxic mitophagy. EMBO Rep. 2017, 18, 495–509. https://doi.org/10.15252/embr.201643309.

  • 66.

    Wu, W.; Lin, C.; Wu, K.; et al. FUNDC1 regulates mitochondrial dynamics at the ER–mitochondrial contact site under hypoxic conditions. EMBO J. 2016, 35, 1368–1384. https://doi.org/10.15252/embj.201593102.

  • 67.

    Faget, D.V.; Ren, Q.; Stewart, S.A. Unmasking senescence: Context-dependent effects of SASP in cancer. Nat. Rev. Cancer 2019, 19, 439–453. https://doi.org/10.1038/s41568-019-0156-2.

  • 68.

    Enzan, N.; Matsushima, S.; Ikeda, S.; et al. ZBP1 Protects Against mtDNA-Induced Myocardial Inflammation in Failing Hearts. Circ. Res. 2023, 132, 1110–1126. https://doi.org/10.1161/circresaha.122.322227.

  • 69.

    Remex, N.S.; Miah, M.S.; Islam, T.; et al. Endothelial mitochondrial homeostasis in the development and progression of atherosclerosis. Front. Cardiovasc. Med. 2026, 13, 1813122. https://doi.org/10.3389/fcvm.2026.1813122.

  • 70.

    Eelen, G.; de Zeeuw, P.; Treps, L.; et al. Endothelial Cell Metabolism. Physiol. Rev. 2018, 98, 3–58. https://doi.org/10.1152/physrev.00001.2017.

  • 71.

    Mussbacher, M.; Schossleitner, K.; Kral-Pointner, J.B.; et al. More than Just a Monolayer: The Multifaceted Role of Endothelial Cells in the Pathophysiology of Atherosclerosis. Curr. Atheroscler. Rep. 2022, 24, 483–492. https://doi.org/10.1007/s11883-022-01023-9.

  • 72.

    Wu, W.; Xu, H.; Wang, Z.; et al. PINK1-Parkin-Mediated Mitophagy Protects Mitochondrial Integrity and Prevents Metabolic Stress-Induced Endothelial Injury. PLoS ONE 2015, 10, e0132499. https://doi.org/10.1371/journal.pone.0132499.

  • 73.

    Xi, J.; Rong, Y.; Zhao, Z.; et al. Scutellarin ameliorates high glucose-induced vascular endothelial cells injury by activating PINK1/Parkin-mediated mitophagy. J. Ethnopharmacol. 2021, 271, 113855. https://doi.org/10.1016/j.jep.2021.113855.

  • 74.

    Zhu, W.; Yuan, Y.; Liao, G.; et al. Mesenchymal stem cells ameliorate hyperglycemia-induced endothelial injury through modulation of mitophagy. Cell Death Dis. 2018, 9, 837. https://doi.org/10.1038/s41419-018-0861-x.

  • 75.

    Lee, I.; Piao, S.; Kim, S.; et al. IDH2 Deficiency Promotes Endothelial Senescence by Eliciting miR-34b/c-Mediated Suppression of Mitophagy and Increased ROS Production. Antioxidants 2023, 12, 585. https://doi.org/10.3390/antiox12030585.

  • 76.

    Ma, L.; Li, K.; Wei, W.; et al. Exercise protects aged mice against coronary endothelial senescence via FUNDC1-dependent mitophagy. Redox Biol. 2023, 62, 102693. https://doi.org/10.1016/j.redox.2023.102693.

  • 77.

    Pei, Y.; Ren, D.; Yin, Y.; et al. Endothelial FUNDC1 Deficiency Drives Pulmonary Hypertension. Circ. Res. 2025, 136, e1–e19. https://doi.org/10.1161/circresaha.124.325156.

  • 78.

    Bentzon, J.F.; Otsuka, F.; Virmani, R.; et al. Mechanisms of Plaque Formation and Rupture. Circ. Res. 2014, 114, 1852–1866. https://doi.org/10.1161/circresaha.114.302721.

  • 79.

    Gimbrone, M.A.; García-Cardeña, G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ. Res. 2016, 118, 620–636. https://doi.org/10.1161/circresaha.115.306301.

  • 80.

    Islam, T. Impact of statins on vascular smooth muscle cells and relevance to atherosclerosis. J. Physiol. 2020, 598, 2295–2296. https://doi.org/10.1113/jp279774.

  • 81.

    Botts, S.R.; Fish, J.E.; Howe, K.L. Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights into Pathogenesis and Treatment. Front. Pharmacol. 2021, 12, 787541. https://doi.org/10.3389/fphar.2021.787541.

  • 82.

    Ponnuswamy, P.; Schröttle, A.; Ostermeier, E.; et al. eNOS Protects from Atherosclerosis Despite Relevant Superoxide Production by the Enzyme in apoE−/− Mice. PLoS ONE 2012, 7, e30193. https://doi.org/10.1371/journal.pone.0030193.

  • 83.

    Ryoo, S.; Gupta, G.; Benjo, A.; et al. Endothelial Arginase II. Circ. Res. 2008, 102, 923–932. https://doi.org/10.1161/circresaha.107.169573.

  • 84.

    Böger, R.H. Asymmetric dimethylarginine: Understanding the physiology, genetics, and clinical relevance of this novel biomarker. Pharmacol. Res. 2009, 60, 447. https://doi.org/10.1016/j.phrs.2009.10.001.

  • 85.

    Ramírez, R.; Ceprian, N.; Figuer, A.; et al. Endothelial Senescence and the Chronic Vascular Diseases: Challenges and Therapeutic Opportunities in Atherosclerosis. J. Pers. Med. 2022, 12, 215. https://doi.org/10.3390/jpm12020215.

  • 86.

    Wu, C.M.; Zheng, L.; Wang, Q.; et al. The emerging role of cell senescence in atherosclerosis. Clin. Chem. Lab. Med. 2021, 59, 27–38. https://doi.org/10.1515/cclm-2020-0601.

  • 87.

    Mao, Y.; Luo, W.; Zhang, L.; et al. STING–IRF3 Triggers Endothelial Inflammation in Response to Free Fatty Acid-Induced Mitochondrial Damage in Diet-Induced Obesity. Arterioscler. Thromb. Vasc. Biol. 2017, 37, 920–929. https://doi.org/10.1161/atvbaha.117.309017. Correction in Arterioscler. Thromb. Vasc. Biol. 2018, 38, e60.

  • 88.

    Iyer, S.S.; He, Q.; Janczy, J.R.; et al. Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation. Immunity 2013, 39, 311–323. https://doi.org/10.1016/j.immuni.2013.08.001.

  • 89.

    Nagar, A.; Bharadwaj, R.; Shaikh, M.O.F.; et al. What are NLRP3-ASC specks? an experimental progress of 22 years of inflammasome research. Front. Immunol. 2023, 14, 1188864. https://doi.org/10.3389/fimmu.2023.1188864.

  • 90.

    Subramanian, N.; Natarajan, K.; Clatworthy, M.R.; et al. The Adaptor MAVS Promotes NLRP3 Mitochondrial Localization and Inflammasome Activation. Cell 2013, 153, 348–361. https://doi.org/10.1016/j.cell.2013.02.054.

  • 91.

    Grebe, A.; Hoss, F.; Latz, E. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. Circ. Res. 2018, 122, 1722–1740. https://doi.org/10.1161/circresaha.118.311362.

  • 92.

    Aronova, A.; Tosato, F.; Naser, N.; et al. Innate Immune Pathways in Atherosclerosis—From Signaling to Long-Term Epigenetic Reprogramming. Cells 2023, 12, 2359. https://doi.org/10.3390/cells12192359.

  • 93.

    Jiang, B.; Bai, F.; Hu, Y.; et al. Endothelial major vault protein alleviates vascular remodeling via promoting Parkin-mediated mitophagy. Nat. Commun. 2025, 16, 4365. https://doi.org/10.1038/s41467-025-59644-y.

  • 94.

    Liu, X.; Jin, Y.; Li, Z.; et al. Dingxin recipe III ameliorates endothelial cell senescence in atherosclerosis by activating the FOXO3a/PINK1/Parkin axis. J. Ethnopharmacol. 2026, 354, 120525. https://doi.org/10.1016/j.jep.2025.120525.

  • 95.

    Duan, M.; Chen, H.; Yin, L.; et al. Mitochondrial apolipoprotein A-I binding protein alleviates atherosclerosis by regulating mitophagy and macrophage polarization. Cell Commun. Signal. 2022, 20, 60. https://doi.org/10.1186/s12964-022-00858-8.

  • 96.

    Docherty, C.K.; Bresciani, J.; Carswell, A.; et al. An Inducible and Vascular Smooth Muscle Cell-Specific Pink1 Knockout Induces Mitochondrial Energetic Dysfunction during Atherogenesis. Int. J. Mol. Sci. 2021, 22, 9993. https://doi.org/10.3390/ijms22189993.

  • 97.

    Jin, H.; Zhu, Y.; Li, Y.; et al. BDNF-mediated mitophagy alleviates high-glucose-induced brain microvascular endothelial cell injury. Apoptosis 2019, 24, 511–528. https://doi.org/10.1007/s10495-019-01535-x.

  • 98.

    Sedding, D.G.; Boyle, E.C.; Demandt, J.A.F.; et al. Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease. Front. Immunol. 2018, 9, 706. https://doi.org/10.3389/fimmu.2018.00706.

  • 99.

    Poellinger, L.; Johnson, R.S. HIF-1 and hypoxic response: The plot thickens. Curr. Opin. Genet. Dev. 2004, 14, 81–85. https://doi.org/10.1016/j.gde.2003.12.006.

  • 100.

    Wang, C.; Dai, X.; Wu, S.; et al. FUNDC1-dependent mitochondria-associated endoplasmic reticulum membranes are involved in angiogenesis and neoangiogenesis. Nat. Commun. 2021, 12, 2616. https://doi.org/10.1038/s41467-021-22771-3. Correction in Nat. Commun. 2024, 15, 4572.

  • 101.

    Wang, X.; Han, X.; Liu, N. FUNDC1 mediated mitophagy alleviates rat aortic smooth muscle cell proliferation, migration induced by angiotensin II. Atherosclerosis 2017, 263, e132. https://doi.org/10.1016/j.atherosclerosis.2017.06.420.

  • 102.

    Ma, K.; Zhang, Z.; Chang, R.; et al. Dynamic PGAM5 multimers dephosphorylate BCL-xL or FUNDC1 to regulate mitochondrial and cellular fate. Cell Death Differ. 2020, 27, 1036–1051. https://doi.org/10.1038/s41418-019-0396-4.

  • 103.

    Jiang, T.; Peng, D.; Shi, W.; et al. IL-6/STAT3 Signaling Promotes Cardiac Dysfunction by Upregulating FUNDC1-Dependent Mitochondria-Associated Endoplasmic Reticulum Membranes Formation in Sepsis Mice. Front. Cardiovasc. Med. 2022, 8, 790612. https://doi.org/10.3389/fcvm.2021.790612.

Share this article:
How to Cite
Ren, D.; Liao, X. Mitophagy in Endothelial Senescence: Implications for Atherosclerosis. iCirculation 2026, 1 (3), 17. https://doi.org/10.53941/icirculation.2026.100017.
RIS
BibTex
Copyright & License
article copyright Image
Copyright (c) 2026 by the authors.
Article Metrics
22
Article Views
0
Citations